EpiEndo Pharmaceuticals ('EpiEndo' or the 'Company'), a clinical-stage biopharmaceutical company developing a new class of oral anti-inflammatory drugs which enhance the host defence response to ...
EpiEndo Pharmaceuticals (‘EpiEndo’ or the ‘Company’), a clinical-stage biopharmaceutical company developing a new class of oral anti-inflammatory drugs which enhance the host defence response to ...
REYKJAVIK, Iceland, June 11, 2025--(BUSINESS WIRE)--EpiEndo Pharmaceuticals (‘EpiEndo’ or the ‘Company’), a clinical-stage biopharmaceutical company developing a new class of oral anti-inflammatory ...
Among adults treated for community-acquired pneumonia in the outpatient setting, broad-spectrum antibiotics vs macrolide monotherapy were associated with an increased risk for adverse drug events.
Researchers have combined the bacteria-killing actions of two classes of antibiotics into one, demonstrating that their new dual-action antibiotic could make bacterial resistance (almost) an ...
Antibiotics are medications that treat bacterial infections. They achieve this by killing bacteria or slowing their growth. Some common types of antibiotics include penicillin and macrolides. Medical ...
Geriatric pharmacology is a challenging field of medical practice. This is because aging causes changes in body structure, function, composition, and metabolic pathways. In addition, older adults have ...
Niigata, Japan - Scientists from Niigata University discover macrolide-based molecules that increase the expression of DEL-1 protein and help in bone regeneration Periodontitis is characterized by the ...
Periodontitis is characterized by the loss of teeth resulting from inflammation of gums due to bacterial infections. The susceptibility to such bone loss disorders increases with age. The expression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results